Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 9 (September)

1. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
   J Med Genet, 44(9): 606-8. [Abstract] [Full-text]
2. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression.
   FASEB J, 21(11): 2753-64. [Abstract] [Full-text]
3. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
   Biochemistry, 46(36): 10317-27. [Abstract] [Full-text]
4. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.
   Neurology, 69(10): 998-1005. [Abstract] [Full-text]
5. Spatial cognition and the human navigation network in AD and MCI.
   Neurology, 69(10): 986-97. [Abstract] [Full-text]
6. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.
   J Chem Neuroanat, 34(3): 102-7. [Abstract] [Full-text]
7. Attentional distractibility by optokinetic stimulation in Alzheimer disease.
   Neurology, 69(11): 1105-12. [Abstract] [Full-text]
8. Peripheral insulin and brain structure in early Alzheimer disease.
   Neurology, 69(11): 1094-104. [Abstract] [Full-text]
9. Mediterranean diet and Alzheimer disease mortality.
   Neurology, 69(11): 1084-93. [Abstract] [Full-text]
10. Downregulation of myosin II-B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cells.
    Biochem Biophys Res Commun, 362(3): 633-8. [Abstract] [Full-text]
11. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects.
    J Neurol Sci, 262(1): 27-36. [Abstract] [Full-text]
12. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1050-5. [Abstract] [Full-text]
13. Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1056-63. [Abstract] [Full-text]
14. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 78(10): 1069-71. [Abstract] [Full-text]
15. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1064-8. [Abstract] [Full-text]
16. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.
    Eur J Neurol, 14(10): 1176-8. [Abstract] [Full-text]
17. Biomarkers for Alzheimer's disease.
    Expert Rev Mol Diagn, 7(5): 635-46. [Abstract] [Full-text]
18. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.
    Neurology, 69(13): 1331-41. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.